Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition

J Cutan Med Surg. Sep/Oct 2017;21(2_suppl):2S-40S. doi: 10.1177/1203475417722552.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Humans
  • Interleukin-17 / antagonists & inhibitors*
  • Psoriasis / drug therapy*

Substances

  • Antibodies, Monoclonal
  • IL17A protein, human
  • Interleukin-17